Cargando…
Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come
Autores principales: | Alam, John J., Nixon, Ralph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636858/ https://www.ncbi.nlm.nih.gov/pubmed/37946303 http://dx.doi.org/10.1186/s13024-023-00678-5 |
Ejemplares similares
-
Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come
por: Alam, John J., et al.
Publicado: (2023) -
Correction: Silencing of Cholinergic Basal Forebrain Neurons Using Archaerhodopsin Prolongs Slow-Wave Sleep in Mice
Publicado: (2015) -
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
por: Jiang, Ying, et al.
Publicado: (2022) -
The cholinergic basal forebrain in the ferret and its inputs to the auditory cortex
por: Bajo, Victoria M, et al.
Publicado: (2014) -
Glutathione S Transferase Activity in the Basal Forebrain Cholinergic Population
por: Francis, A., et al.
Publicado: (1992)